Loading articles...
Pfizer Trial Supports Paxlovid Dose for High-Risk Children
A recent trial supports the use of Paxlovid in high-risk paediatric patients, aligning with adult dosing for similar risk profiles.
Public Health Measures Significantly Reduced COVID-19 Incidence
A systematic review and meta-analysis confirmed the effectiveness of public health measures in reducing COVID-19 incidence, transmission, and mortality.
Data Integrity Concerns Raised in Pfizer's COVID-19 Vaccine Trial
A former regional director for Ventavia Research Group has raised concerns regarding data integrity and regulatory oversight in Pfizer's COVID-19 vaccine trial.
DRC Ebola Outbreak Exposes Global Health Underfunding Consequences
The 2026 BMJ study highlights how the Democratic Republic of Congo's Ebola outbreak revealed critical deficiencies in global health funding.
Ebola Outbreak May Become Deadliest on Record, Agencies Warn
Aid agencies caution that the current Ebola outbreak has the potential to become the deadliest recorded, according to a recent report.
Ebola: Essential Information for Suspected Cases
Ebola virus disease (EVD) presents a significant public health concern. Rapid identification and isolation are critical for containment.
Three Vaccines in Development for Bundibugyo Ebola Outbreak
Three investigational vaccines are being fast-tracked for development following an Ebola Bundibugyo outbreak, addressing a critical unmet need.
New Plasmodium falciparum Imaging Platform Advances Malaria Vaccine Development
A novel marker-free transgenic Plasmodium falciparum line, NF54-mCh, offers robust, life cycle-wide fluorescence, accelerating malaria research and vaccine development.
Multivalent Meningococcal Conjugate Vaccines Modelled for African Belt
A new model evaluates multivalent meningococcal conjugate vaccines (MMCVs) in the African meningitis belt, assessing optimal vaccination strategies.